 |
|
Selective Causes of Fever in Adult Human Immunodeficiency Virus—Infected Patients Relative to CD4+ Cell Counts
John S. Czachor, MD;
Richard A. Gleckman, MD
Arch Fam Med. 1995;4(10):879-884.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41:1-19.
PUBMED
2. Centers for Disease Control and Prevention. The second 100,000 cases of acquired immunodeficiency syndrome—United States, June 1981-December 1991. MMWR Morb Mortal Wkly Rep. 1992;41:28-29.
PUBMED
3. Clark RA, Brandon W, Dumestre J, Pindaro C. Clinical manifestations of infection with the human immunodeficiency virus in women in Louisiana. Clin Infect Dis. 1993;17:165-172.
PUBMED
4. White K. Highlights from the national conference on women and HIV infection, part 2: case definition and clinical trial changes. AIDS Patient Care. 1991;5:70-72.
5. Centers for Disease Control and Prevention. Heterosexually-acquired AIDS—United States, 1993. MMWR Morb Mortal Wkly Rep. 1994;43:155-160.
PUBMED
6. Stein DS, Korvick JA, Vermund SH. CD4 lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis. 1992;165:352-363.
PUBMED
7. Levy JA. The transmission of HIV and factors influencing progression to AIDS. Am J Med. 1993;95:86-100.
PUBMED
8. Yarchoan R, Venzon DJ, Pluda JM, et al. CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy. Ann Intern Med. 1991;115:184-189.
FREE FULL TEXT
9. Hirsch MS, D'Aquila RT. Therapy for human immunodeficiency virus infection. N Engl J Med. 1993;328:1686-1695.
FREE FULL TEXT
10. Weiss PJ, Brodine SK, Goforth RR, et al. Initial low CD4 lymphocyte counts in recent human immunodeficiency virus infection and lack of association with identified coinfections. J Infect Dis. 1992;166:1149-1153.
PUBMED
11. Centers for Disease Control and Prevention. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex for adults and adolescents infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1993;42:14-20.
PUBMED
12. Centers for Disease Control and Prevention. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1992;41:1-11.
PUBMED
13. Lenderking WR, Gelber RD, Colton DJ, et al. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. N Engl J Med. 1994;330:738-743.
FREE FULL TEXT
14. Masur H, Ognibene FP, Yarchoan R, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med. 1989:111:223-231.
FREE FULL TEXT
15. Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N Engl J Med. 1990;322:161-165.
ABSTRACT
16. Sepkowitz KA, Telzak EE, Carrow M, Armstrong D. Fever among outpatients with advanced human immunodeficiency virus infection. Arch Intern Med. 1993;153:1909-1912.
FREE FULL TEXT
17. Niu MT, Stein DS, Schnittman SM. Primary human immunodeficiency virus type 1 infection. J Infect Dis. 1993;168:1490-1501.
PUBMED
18. Cooper DA, Gold J, MacLean P, et al. Acute AIDS retrovirus infection. Lancet. 1985;1:537-540.
PUBMED
19. Kinloch-de Loés S, de Saussure P, Saurat JH, Stadler H, Hirschel B, Perrin LH. Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases. Clin Infect Dis. 1993;17:59-65.
PUBMED
20. Sabbatini P, Neuzil KM, Morgan HJ. Prolonged fever in a young woman. J Tenn Med Assoc. 1991;84:76.
PUBMED
21. Coutleé F, Olivier C, Cassol S, et al. Absence of prolonged immunosilent infection with human immunodeficiency virus in individuals with highrisk behaviors. Am J Med. 1994;96:42-48.
PUBMED
22. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev. 1993;57:183-289.
FREE FULL TEXT
23. Pedersen C, Lindhardt BO, Jensen BL, et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ. 1989;299:154-157.
FREE FULL TEXT
24. Keet IPM, Krijnen P, Koot M, et al. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS. 1993;7:51-57.
PUBMED
25. Katz MH, Bindman AB, Keane D, Chan AK. CD4 lymphocyte count as an indicator of delay in seeking human immunodeficiency virus-related treatment. Arch Intern Med. 1992;152:1501-1504.
FREE FULL TEXT
26. Cooper DA, Tindall B, Wilson El, Imrie AA, Penny R. Characterization of T lymphocyte responses during primary infection with human immunodeficiency virus. J Infect Dis. 1988;157:889-896
PUBMED
27. Gaines H, von Sydow MAE, von Stedingk LV, et al. Immunological changes in primary HIV-1 infection. AIDS. 1990;4:995-999.
PUBMED
28. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions. JAMA. 1986;256:3358-3363.
FREE FULL TEXT
29. Lee BL, Safrin S. Interactions and toxicities of drugs used in patients with AIDS. Clin Infect Dis. 1992;14:773-779.
PUBMED
30. Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med. 1993;328:1670-1674.
FREE FULL TEXT
31. Torres RA, Lin RY, Lee M, Barr MR. Zidovudineinduced leukocytoclastic vasculitis. Arch Intern Med. 1992;152:850-851.
FREE FULL TEXT
32. Borucki MJ, Matzke DS, Pollard RB. Tremor induced by trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1988;109:77-78.
PUBMED
33. Kennedy CA, Pimentel JA, Lewis DE, Anderson MD, Weiss PJ, Oldfield EC III. Crossover of human immunodeficiency virus-infected patients from aerosolized pentamidine to trimethoprimsulfamethoxazole. J Infect Dis. 1993;168:314-317.
PUBMED
34. Mackowiak PA, LeMaistre CF. Drug fever: a critical appraisal of conventional concepts. Ann Intern Med. 1987;106:728-733.
FREE FULL TEXT
35. Nguyen BY, Landucci DL, Cunnion RE, Yarchoan R, Walker RE. A case of hyperdynamic shock caused by trimethoprim-sulfamethoxazole in which no tumor necrosis factor or features of anaphylaxis were detected. Clin Infect Dis. 1993;17:885-887.
PUBMED
36. Caumes E, Roudier C, Rogeaux O, Bricaire F, Gentilini M. Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis cariniipneumonia. Clin Infect Dis. 1994;18:319-323.
PUBMED
37. Jacobson MA, McGrath MS, Joseph P, Molaghan JB, Tadepalli S, Quinn R. Zidovudineinduced fever. J Acquir Immune Defic Syndr. 1989;2:382-388.
PUBMED
38. Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence. MMWR Morb Mortal Wkly Rep. 1993;42:1-18.
PUBMED
39. Hibberd PL, Rubin RH. Approach to immunization in the immunosuppressed host. Infect Dis Clin North Am. 1990;4:123-142.
PUBMED
40. Lang W, Perkins H, Anderson RE, Royce R, Jewell N, Winkelstein W Jr. Patterns of T lymphocyte changes with human immunodeficiency virus infection. J Acquir Immune Defic Syndr. 1989;2:63-69.
PUBMED
41. Turner BJ, Hecht FM, Ismail RB. CD4+ lymphocyte measures in the treatment of individuals infected with human immunodeficiency virus type 1. Arch Intern Med. 1994;154:1561-1573.
FREE FULL TEXT
42. Koot M, Keet IP, Vos AH, et al. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med. 1993;118:681-688.
FREE FULL TEXT
43. Bozzette SA, McCutchan JA, Spector SA, Wright B, Richman DD. A cross-sectional comparison of persons with syncytium- and nonsyncytium-inducing human immunodeficiency virus. J Infect Dis. 1993;168:1374-1379.
PUBMED
44. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med. 1987;317:185-191.
ABSTRACT
45. Volberding PA, Lagakus SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection. N Engl J Med. 1990;322:941-949.
ABSTRACT
46. Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med. 1987;317:192-197.
ABSTRACT
47. Gradon JD, Timpone JG, Schnittman SM. Emergence of unusual opportunistic pathogens in AIDS: a review. Clin Infect Dis. 1992;15:134-157.
PUBMED
48. Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Engl J Med. 1993;329:1922-1926.
FREE FULL TEXT
49. Stein M, O'Sullivan P, Wachtel T, et al. Causes of death in persons with human immunodeficiency virus infection. Am J Med. 1992;93:387-390.
PUBMED
50. Rodriguez-Barradas MC, Musher DM, Lahart C, et al. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis. 1992;165:553-556.
PUBMED
51. Gordin F, Gibert C, Schmidt ME. Clostridium difficile colitis associated with trimethoprimsulfamethoxazole given as prophylaxis for Pneumocystis carinii pneumonia. Am J Med. 1994;96:94-95.
PUBMED
52. Fineman DS, Palestro CJ, Kim CK, et al. Detection of abnormalities in febrile AIDS patients with In-III-labeled leukocyte and Ga-67 scintigraphy. Radiology. 1989;170:677-680.
FREE FULL TEXT
53. Godofsky EW, Zinreich J, Armstrong M, Leslie JM, Weikel CS. Sinusitis in HIV-infected patients: a clinical and radiographic review. Am J Med. 1992;93:163-170.
PUBMED
54. O'Donnell JG, Sorbello AF, Condoluci DV, Barnish MJ. Sinusitis due to Pseudomonas aeruginosa in patients with human immunodeficiency virus infection. Clin Infect Dis. 1993;16:404-406.
PUBMED
55. Butkus Small C, Kaufman A, Armenaka M, Rosenstriech DL. Sinusitis and atopy in human immunodeficiency virus infection. J Infect Dis. 1993;167:283-290.
PUBMED
56. Zurlo JJ, Feuerstein IM, Lebovics R, Lane HC. Sinusitis and HIV-1 infection. Am J Med. 1992:93:157-162.
PUBMED
57. Glesky MJ, Moore RD, Chaisson RE, Zidovudine Epidemiology Study Group. Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. J Infect Dis. 1993;168:1264-1268.
PUBMED
58. Melbye M, Grossman RJ, Goedert JJ, Eyster ME, Biggar RJ. Risk of AIDS after herpes zoster. Lancet. 1987;1:728-731.
PUBMED
59. Friedman-Kien AE, Lafleur FL, Gendler E, et al. Herpes zoster. J Am Acad Dermatol. 1986;14:1023-1028.
PUBMED
60. Buchbinder SP, Katz MH, Hessol NA, et al. Herpes zoster and human immunodeficiency virus infection. J Infect Dis. 1992;166:1153-1156.
PUBMED
61. Hoepelman Al, van Buren M, Van den Broek J, Borleffs JC. Bacteriuria in men infected with HIV-1 is related to their immune status (CD4 + cell count). AIDS. 1992;6:179-184.
PUBMED
62. Paddock CD, Suchard DP, Grumbach KL, et al. Brief report: fatal seronegative ehrlichiosis in a patient with HIV infection. N Engl J Med. 1993;329:1164-1167.
FREE FULL TEXT
63. Frickhofen N, Abkowitz JL, Safford M, et al. Persistent B19 parovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1). Ann Intern Med. 1990;113:926-933.
FREE FULL TEXT
64. Galgiani JN, Ampel NM. Coccidioidomycosis in human immunodeficiency virus-infected patients. J Infect Dis. 1990;162:1165-1169.
PUBMED
65. Mandell W, Goldberg DM, Neu HC. Histoplasmosis in patients with the acquired immune deficiency syndrome. Am J Med. 1986;81:974-978.
PUBMED
66. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med. 1992;327:1643-1648.
ABSTRACT
67. Prego V, Glatt AE, Roy V, Thelmo W, Dincsoy H, Raufman JP. Comparative yield of blood culture for fungi and mycobacteria, liver biopsy, and bone marrow biopsy in the diagnosis of fever of undetermined origin in human immunodeficiency virus-infected patients. Arch Intern Med. 1990;150:333-336.
FREE FULL TEXT
68. Selwyn PA, Alcabes P, Hartel D, et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med. 1992;327:1697-1703.
ABSTRACT
69. Palenicek J, Nelson KE, Vlahov D, Galai N, Cohn S, Saah AJ. Comparison of clinical symptoms of human immunodeficiency virus disease between intravenous drug users and homosexual men. Arch Intern Med. 1993;153:1806-1812.
FREE FULL TEXT
70. Barat LM, Craven DE, Steinberg JL, Viner BL, Steger KA, Rice PA. A prospective study of documented fever in patients infected with HIV-1: diagnosis and outcome in a municipal hospital. In: Program and abstracts of the Seventh International Conference on AIDS; June 16-21, 1991; Florence, Italy. Abstract MB2413. 71. Barat LM, Gunn JE, Steger KA, et al. Bacterial infections are the most common cause of fever in HIV-infected patients admitted to a municipal hospital. In: Program and abstracts of the Eighth International Conference on AIDS; July 19-24, 1992; Amsterdam, the Netherlands. Abstract POB3832. 72. O'Connor PG, Selwyn PA, Schottenfeld RS. Medical care for injection-drug users with human immunodeficiency virus infection. N Engl J Med. 1994;331:450-459.
FREE FULL TEXT
73. Sattler FR, Ko R, Antoniskis D, et al. Acetaminophen does not impair clearance of zidovudine. Ann Intern Med. 1991;114:937-940.
FREE FULL TEXT
74. Shriner K, Goetz MB. Severe hepatotoxicity in a patient receiving both acetaminophen and zidovudine. Am J Med. 1992;93:94-96.
PUBMED
75. Glaser CA, Angulo FJ, Rooney JA. Animalassociated opportunistic infections among persons infected with the human immunodeficiency virus. Clin Infect Dis. 1994;18:14-24.
PUBMED
76. Fleming PL, Ciesielski CA, Byers RH, Castro KG, Berkelman RL. Gender differences in reported AIDS indicative diagnoses. J Infect Dis. 1993;168:61-67.
PUBMED
77. Hughes MD, Stein DS, Gundacker H, Valentine FT, Phair JP, Volberding PA. Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection. J Infect Dis. 1994;169:28-36.
PUBMED
|
